title: Enhanced sensitivity for selected reaction monitoring mass spectrometry-based targeted proteomics using a dual stage electrodynamic ion funnel interface.
abstract: Selected reaction monitoring mass spectrometry (SRM-MS) is playing an increasing role in quantitative proteomics and biomarker discovery studies as a method for high throughput candidate quantification and verification. Although SRM-MS offers advantages in sensitivity and quantification compared with other MS-based techniques, current SRM technologies are still challenged by detection and quantification of low abundance proteins (e.g. present at ∼10 ng/ml or lower levels in blood plasma). Here we report enhanced detection sensitivity and reproducibility for SRM-based targeted proteomics by coupling a nanospray ionization multicapillary inlet/dual electrodynamic ion funnel interface to a commercial triple quadrupole mass spectrometer. Because of the increased efficiency in ion transmission, significant enhancements in overall signal intensities and improved limits of detection were observed with the new interface compared with the original interface for SRM measurements of tryptic peptides from proteins spiked into non-depleted mouse plasma over a range of concentrations. Overall, average SRM peak intensities were increased by ∼70-fold. The average level of detection for peptides also improved by ∼10-fold with notably improved reproducibility of peptide measurements as indicated by the reduced coefficients of variance. The ability to detect proteins ranging from 40 to 80 ng/ml within mouse plasma was demonstrated for all spiked proteins without the application of front-end immunoaffinity depletion and fractionation. This significant improvement in detection sensitivity for low abundance proteins in complex matrices is expected to enhance a broad range of SRM-MS applications including targeted protein and metabolite validation.
authors.affiliation: Biological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington 99352, USA.
authors.forename: Mahmud
authors.initials: M
authors.lastname: Hossain
authors.forename: David T
authors.initials: DT
authors.lastname: Kaleta
authors.forename: Errol W
authors.initials: EW
authors.lastname: Robinson
authors.forename: Tao
authors.initials: T
authors.lastname: Liu
authors.forename: Rui
authors.initials: R
authors.lastname: Zhao
authors.forename: Jason S
authors.initials: JS
authors.lastname: Page
authors.forename: Ryan T
authors.initials: RT
authors.lastname: Kelly
authors.forename: Ronald J
authors.initials: RJ
authors.lastname: Moore
authors.forename: Keqi
authors.initials: K
authors.lastname: Tang
authors.forename: David G
authors.initials: DG
authors.lastname: Camp
authors.forename: Wei-Jun
authors.initials: WJ
authors.lastname: Qian
authors.forename: Richard D
authors.initials: RD
authors.lastname: Smith
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D002417:Cattle; D002645:Chickens; D045304:Cytochromes c / Q000378:metabolism; D004926:Escherichia coli / Q000201:enzymology; D006736:Horses / Q000378:metabolism; D013058:Mass Spectrometry / Q000379:methods*; D051379:Mice; D018482:Muscle, Skeletal / Q000378:metabolism; D009211:Myoglobin / Q000378:metabolism; D010047:Ovalbumin / Q000378:metabolism; D010455:Peptides / Q000737:chemistry; D040901:Proteomics / Q000379:methods*; D014357:Trypsin / Q000737:chemistry
chemical_list: D015415:Biomarkers; D009211:Myoglobin; D010455:Peptides; D010047:Ovalbumin; D045304:Cytochromes c; D014357:Trypsin
references.citation: J Am Soc Mass Spectrom. 2006 Sep;17(9):1299-305
references.pmid: 16839773
references.citation: Anal Chem. 2008 Jan 1;80(1):143-9
references.pmid: 18044958
references.citation: Mol Syst Biol. 2008;4:222
references.pmid: 18854821
references.citation: Anal Chem. 2001 Sep 1;73(17):4162-70
references.pmid: 11569805
references.citation: Anal Chem. 2009 May 1;81(9):3462-70
references.pmid: 19323455
references.citation: Nat Biotechnol. 2006 Aug;24(8):971-83
references.pmid: 16900146
references.citation: Clin Chem. 2009 Jun;55(6):1108-17
references.pmid: 19372185
references.citation: Biomark Insights. 2007 Oct 03;2:347-60
references.pmid: 19662217
references.citation: Nat Rev Cancer. 2005 Nov;5(11):845-56
references.pmid: 16239904
references.citation: Mass Spectrom Rev. 2010 Mar-Apr;29(2):294-312
references.pmid: 19391099
references.citation: Anal Chem. 2006 Nov 15;78(22):7796-801
references.pmid: 17105173
references.citation: Mol Cell Proteomics. 2002 Nov;1(11):845-67
references.pmid: 12488461
references.citation: Mol Oncol. 2009 Feb;3(1):33-44
references.pmid: 19383365
references.citation: Anal Chem. 2000 May 15;72(10):2247-55
references.pmid: 10845370
references.citation: Proteomics Clin Appl. 2008 Oct;2(10-11):1403-12
references.pmid: 21136789
references.citation: Anal Chem. 2008 Jan 1;80(1):294-302
references.pmid: 18044960
references.citation: Nat Biotechnol. 2009 Jul;27(7):633-41
references.pmid: 19561596
references.citation: Clin Chem. 2008 Nov;54(11):1749-52
references.pmid: 18957555
references.citation: Brief Funct Genomic Proteomic. 2009 Mar;8(2):126-35
references.pmid: 19109305
references.citation: Mol Cell Proteomics. 2006 Oct;5(10):1727-44
references.pmid: 16887931
references.citation: Mol Cell Proteomics. 2006 Apr;5(4):573-88
references.pmid: 16332733
references.citation: Biomark Insights. 2007 Feb 07;1:1-48
references.pmid: 19690635
references.citation: Nature. 2008 Apr 3;452(7187):571-9
references.pmid: 18385731
references.citation: Mol Cell Proteomics. 2008 Oct;7(10):1963-73
references.pmid: 18632595
references.citation: Mol Cell Proteomics. 2009 Aug;8(8):1860-77
references.pmid: 19411661
references.citation: Proteomics. 2003 Apr;3(4):422-32
references.pmid: 12687610
references.citation: Anal Chem. 1999 Aug 1;71(15):2957-64
references.pmid: 10450147
references.citation: Mol Cell Proteomics. 2007 Dec;6(12):2212-29
references.pmid: 17939991
references.citation: J Am Soc Mass Spectrom. 2007 Sep;18(9):1582-90
references.pmid: 17627841